Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Life360
LIF
5
Tempus AI
TEM
US Stock MarketDetailed Quotes
Madrigal Pharmaceuticals (MDGL)
- 311.140
- -8.730-2.73%
Close Jul 15 15:59 ET
- 306.140
- -5.000-1.61%
Pre 04:22 ET
6.91BMarket Cap-17.44P/E (TTM)
322.500High307.430Low274.08KVolume322.500Open319.870Prev Close85.18MTurnover2.50%Turnover RatioLossP/E (Static)22.20MShares377.46052wk High9.72P/B3.41BFloat Cap200.63052wk Low--Dividend TTM10.96MShs Float415.800Historical High--Div Yield TTM4.71%Amplitude6.600Historical Low310.787Avg Price1Lot Size
Madrigal Pharmaceuticals (MDGL) Income Statement
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 137.25M | 180.13M | 103.32M | 62.18M | 14.64M | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --137.25M | --180.13M | --103.32M | --62.18M | --14.64M | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 4.51M | 6.23M | 3.45M | 2.15M | 636K | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 132.74M | 173.9M | 99.88M | 60.02M | 14M | 0 | 0 | 0 | 0 | 0 |
| Operating expense | 39.47%212.05M | 76.55%671.78M | 42.41%166.87M | 78.95%176.33M | 104.21%176.54M | 94.08%152.04M | 29.61%380.5M | 37.37%117.18M | 22.54%98.53M | 23.02%86.45M |
| Selling and administrative expenses | 107.77%167.88M | 302.29%435.06M | 203.47%141.22M | 290.04%107.59M | 490.91%105.45M | 399.32%80.8M | 124.70%108.15M | 219.68%46.54M | 127.19%27.58M | 51.56%17.85M |
| -General and administrative expense | ---- | ---- | ---- | 290.04%107.59M | ---- | ---- | ---- | ---- | 127.19%27.58M | ---- |
| Research and development costs | -37.99%44.17M | -13.08%236.72M | -63.69%25.65M | -3.11%68.74M | 3.62%71.09M | 14.61%71.24M | 10.96%272.35M | -0.14%70.64M | 3.93%70.95M | 17.28%68.61M |
| Operating profit | 47.83%-79.31M | -30.85%-497.88M | 42.82%-67M | -18.03%-116.3M | -88.01%-162.54M | -94.08%-152.04M | -29.61%-380.5M | -37.37%-117.18M | -22.54%-98.53M | -23.02%-86.45M |
| Net non-operating interest income expense | 35.08%6.07M | 365.82%31.98M | 52.15%7.58M | 4,633.98%9.34M | 1,525.54%10.57M | 212.22%4.5M | 485.95%6.87M | 922.11%4.98M | 73.76%-206K | 242.23%650K |
| Non-operating interest income | 12.43%9.37M | 138.30%46.65M | 23.75%11.08M | 294.75%13.02M | 300.51%14.22M | 120.71%8.33M | 796.02%19.58M | 732.06%8.95M | 359.97%3.3M | 999.38%3.55M |
| Non-operating interest expense | -14.10%3.3M | 15.41%14.67M | -11.89%3.5M | 4.99%3.68M | 26.03%3.66M | 64.30%3.84M | 220.69%12.71M | 136.09%3.97M | 133.29%3.5M | 271.92%2.9M |
| Other net income (expense) | ||||||||||
| Income before tax | 50.36%-73.24M | -24.69%-465.89M | 47.04%-59.42M | -8.33%-106.96M | -77.12%-151.97M | -91.87%-147.54M | -26.50%-373.63M | -30.60%-112.19M | -21.61%-98.74M | -21.31%-85.8M |
| Income tax | ||||||||||
| Net income | 50.36%-73.24M | -24.69%-465.89M | 47.04%-59.42M | -8.33%-106.96M | -77.12%-151.97M | -91.87%-147.54M | -26.50%-373.63M | -30.60%-112.19M | -21.61%-98.74M | -21.31%-85.8M |
| Net income continuous Operations | 50.36%-73.24M | -24.69%-465.89M | 47.04%-59.42M | -8.33%-106.96M | -77.12%-151.97M | -91.87%-147.54M | -26.50%-373.63M | -30.60%-112.19M | -21.61%-98.74M | -21.31%-85.8M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 50.36%-73.24M | -24.69%-465.89M | 47.04%-59.42M | -8.33%-106.96M | -77.12%-151.97M | -91.87%-147.54M | -26.50%-373.63M | -30.60%-112.19M | -21.61%-98.74M | -21.31%-85.8M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 50.36%-73.24M | -24.69%-465.89M | 47.04%-59.42M | -8.33%-106.96M | -77.12%-151.97M | -91.87%-147.54M | -26.50%-373.63M | -30.60%-112.19M | -21.61%-98.74M | -21.31%-85.8M |
| Basic earnings per share | 55.01%-3.32 | -9.55%-21.9 | 52.62%-2.71 | 7.87%-4.92 | -51.39%-7.1 | -74.47%-7.38 | -16.02%-19.99 | -14.86%-5.72 | -12.42%-5.34 | -13.29%-4.69 |
| Diluted earnings per share | 55.01%-3.32 | -9.55%-21.9 | 52.62%-2.71 | 7.87%-4.92 | -51.39%-7.1 | -74.47%-7.38 | -16.02%-19.99 | -14.86%-5.72 | -12.42%-5.34 | -13.29%-4.69 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
AI application software AI application software
AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc. AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc.
Unlock Now
Discussing
Focus on tariff dynamics! How to plan most securely in the near future?
Recently, Trump's tariffs have sparked controversy again. Trump stated that the United States would impose a 100% tariff on Russia, a 30% ta
Food流油
Apr 14 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"